We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
Cap. Flow
+$281M
Cap. Flow %
7.02%
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$104M
2
AAPL icon
Apple
AAPL
+$60.7M
3
AMZN icon
Amazon
AMZN
+$47.5M
4
AXP icon
American Express
AXP
+$28.7M
5
TRV icon
Travelers Companies
TRV
+$27.2M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$28.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.1M
3
CLX icon
Clorox
CLX
+$26.2M
4
TJX icon
TJX Companies
TJX
+$24.8M
5
MCK icon
McKesson
MCK
+$23.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.39%
2 Financials 11.87%
3 Technology 10.68%
4 Communication Services 10.67%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVY icon
501
Avery Dennison
AVY
$12.3B
$613K 0.02%
+8,554
New +$553K
MGA icon
502
Magna International
MGA
$17.9B
$613K 0.02%
14,284
-2,110
-13% -$78.5K
TNL icon
503
Travel + Leisure Co
TNL
$4.54B
$613K 0.02%
17,853
-149,736
-89% -$4.75M
HAS icon
504
Hasbro
HAS
$12.6B
$612K 0.02%
7,685
-94,693
-92% -$7.04M
CLVS
505
DELISTED
Clovis Oncology, Inc.
CLVS
$611K 0.02%
32,000
-4,300
-12% -$91K
FTNT icon
506
Fortinet
FTNT
$112B
$609K 0.02%
+100,000
New +$552K
APH icon
507
Amphenol
APH
$188B
$608K 0.02%
+42,284
New +$549K
RNR icon
508
RenaissanceRe
RNR
$13.7B
$608K 0.02%
5,099
-1,118
-18% -$127K
SLAB icon
509
Silicon Laboratories
SLAB
$7.15B
$608K 0.02%
13,600
+7,900
+139% +$340K
CAJ
510
DELISTED
Canon, Inc.
CAJ
$605K 0.02%
+20,400
New +$586K
SJM icon
511
J.M. Smucker
SJM
$12.6B
$604K 0.02%
4,677
-2,053
-31% -$259K
AXS icon
512
AXIS Capital
AXS
$8.59B
$602K 0.02%
10,910
-2,274
-17% -$123K
MTD icon
513
Mettler-Toledo International
MTD
$26.8B
$602K 0.02%
1,757
+171
+11% +$55K
RHI icon
514
Robert Half
RHI
$3.61B
$588K 0.01%
12,688
+2,633
+26% +$110K
VTR icon
515
Ventas
VTR
$48.9B
$577K 0.01%
9,221
+2,098
+29% +$118K
SPY icon
516
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$575K 0.01%
2,810
-1,150
-29% -$224K
WEC icon
517
WEC Energy
WEC
$37.7B
$569K 0.01%
+9,523
New +$533K
PDCO
518
DELISTED
Patterson Companies, Inc.
PDCO
$564K 0.01%
12,194
LNKD
519
DELISTED
LinkedIn Corporation
LNKD
$555K 0.01%
4,878
-3,383
-41% -$497K
PFG icon
520
Principal Financial Group
PFG
$23.6B
$548K 0.01%
13,973
+1,278
+10% +$49.2K
IVZ icon
521
Invesco
IVZ
$13.3B
$546K 0.01%
17,835
+1,624
+10% +$46.9K
AIG icon
522
American International
AIG
$41.9B
$543K 0.01%
+10,093
New +$545K
MTB icon
523
M&T Bank
MTB
$36.2B
$540K 0.01%
4,888
+627
+15% +$68K
CTMX icon
524
CytomX Therapeutics
CTMX
$705M
$539K 0.01%
42,000
+32,000
+320% +$444K
MHK icon
525
Mohawk Industries
MHK
$6.9B
$539K 0.01%
+2,840
New +$494K

Similar funds

Candriam SCA's Q1 2016 Portfolio in Review

As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.

  • Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
  • Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
  • Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
  • Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
  • Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
  • Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
  • Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.

Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.